345
Views
9
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis

, , , , , , , , , , & show all
Pages 439-446 | Received 07 Sep 2009, Accepted 28 May 2010, Published online: 01 Aug 2010
 

Abstract

Introduction. Arterial calcification is a risk factor for atherosclerosis. Calumenin (CALU), a protein regulating proteins involved in coagulation and arterial calcification also has extracellular functions related to atherosclerosis. We recently described that CALU polymorphism A29809G was related to acenocoumarol requirements, and we wanted to evaluate its role in arterial calcification and prognosis.

Patients and methods. A total of 374 consecutive patients with non-ST-elevation acute coronary syndrome (nSTACS). In 175 of them, who underwent percutaneous coronary intervention, we assessed calcification in each main coronary artery. Follow-up at 1 and 6 months was performed for adverse end-points.

Results. CALU 29809G carriers were more frequent in the low calcium group (P = 0.037). The presence of ≥3 cardiovascular risk factors and CALU polymorphism were associated with arterial calcification (OR 2.34, P = 0.049; and OR 0.34, P = 0.019, respectively). CALU 29809G allele was the only variable associated with events at 1 month (HR 0.42; P = 0.042). Multivariate analysis showed that, at 6 months, age and severe anginal symptoms were associated with worse prognosis (HR 2.13, P = 0.023; and HR 2.01, P = 0.011, respectively), whereas CALU 29809G allele associated with good prognosis (HR 0.59, P = 0.044). Our results suggest that CALU A29809G is associated with arterial calcification and short-term prognosis of the outcome of patients with nSTACS.

Acknowledgements

This work was partially supported by 04515/GERM/06 from Fundación Séneca, SAF2009-08993 (MCYT & FEDER), RD06/0014/039 (RECAVA) from ISCIII, and PI081531 from ISCIII. Dr Hernández-Romero holds a post-doctoral position funded by Instituto de Salud Carlos III.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.